[1]
|
Tujios, S.R., Hynan, L.S., Vazquez, M.A., et al. (2015) Risk Factors and Outcomes of Acute Kidney Injury in Patients with Acute Liver Failure. Clinical Gastroenterology and Hepatology, 13, 352-359.
https://doi.org/10.1016/j.cgh.2014.07.011
|
[2]
|
Khwaja, A. (2012) KDIGO Clinical Practice Guidelines for Acute Kidney Injury. Nephron Clinical Practice, 120, c179-c184. https://doi.org/10.1159/000339789
|
[3]
|
陈香美. 血液净化标准操作规程[M]. 北京: 人民卫生出版社, 2021.
|
[4]
|
Schneider, A.G., Journois, D. and Rimmele, T. (2017) Complications of Regional Citrate Anticoagulation: Accumulation or Overload? Critical Care, 21, 281. https://doi.org/10.1186/s13054-017-1880-1
|
[5]
|
Alvarez, G., Chrusch, C., Hulme, T., et al. (2019) Renal Re-placement Therapy: A Practical Update. The Canadian Journal of Anesthesia, 66, 593-604. https://doi.org/10.1007/s12630-019-01306-x
|
[6]
|
白浪, 陈煜, 陈源文, 等. 人工肝血液净化技术临床应用专家共识(2022年版) [J]. 临床肝胆病杂志, 2022, 28(4): 767-775.
|
[7]
|
马元吉, 白浪, 唐红. 局部枸橼酸抗凝在人工肝治疗肝衰竭中的应用研究进展[J]. 中华肝脏病杂志, 2020, 28(6): 532-535. https://doi.org/10.3760/cma.j.cn501113-20200509-00238
|
[8]
|
Yu, Y., Bai, M., Ma, F., et al. (2020) Regional Cit-rate Anticoagulation versus No-Anticoagulation for Continuous Venovenous Hemofiltration in Patients with Liver Fail-ure and Increased Bleeding Risk: A Retrospective Case-Control Study. PLoS ONE, 15, e232516. https://doi.org/10.1371/journal.pone.0232516
|
[9]
|
曹燕, 钱丹, 潘红, 等. 枸橼酸抗凝在脓毒症合并肝功能不全患者持续肾脏替代治疗期间的安全性及有效性研究[J]. 中国实用护理杂志, 2019(32): 2488-2491. https://doi.org/10.3760/cma.j.issn.1672-7088.2019.32.002
|
[10]
|
张春, 林婷, 张靖垚, 等. 局部枸橼酸抗凝在肝切除术后急性肾损伤连续性肾脏替代治疗中临床疗效评价[J]. 中华危重病急救医学, 2018, 30(8): 777-782. https://doi.org/10.3760/cma.j.issn.2095-4352.2018.08.013
|
[11]
|
Bernal, W., Lee, W.M., Wendon, J., et al. (2015) Acute Liver Failure: A Curable Disease by 2024? Journal of Hepatology, 62, S112-S120. https://doi.org/10.1016/j.jhep.2014.12.016
|
[12]
|
Allegretti, A.S., Parada, X.V., Eneanya, N.D., et al. (2018) Prog-nosis of Patients with Cirrhosis and AKI Who Initiate RRT. Clinical Journal of the American Society of Nephrology, 13, 16-25. https://doi.org/10.2215/CJN.03610417
|
[13]
|
Zarbock, A., Kullmar, M., Kindgen-Milles, D., et al. (2020) Effect of Regional Citrate Anticoagulation vs Systemic Heparin Anticoagulation during Continuous Kidney Replacement Therapy on Dialysis Filter Life Span and Mortality among Critically Ill Patients with Acute Kidney Injury: A Randomized Clinical Trial. JAMA, 324, 1629-1639.
https://doi.org/10.1001/jama.2020.18618
|
[14]
|
许俊堂. 肝素诱导的血小板减少症中国专家共识解读[J]. 中国循环杂志, 2018, 33(S2): 117-120.
https://doi.org/10.3969/j.issn.1000-3614.2018.增刊.028
|
[15]
|
杜然, 曾光. 枸橼酸抗凝对行CRRT治疗的肾衰竭患者凝血指标及肝、肾功能的影响[J]. 国际检验医学杂志, 2020, 41(14): 1717-1719. https://doi.org/10.3969/j.issn.1673-4130.2020.14.014
|
[16]
|
章颖, 明芳, 薛红. 局部枸橼酸抗凝在肝衰竭患者连续性静脉-静脉血液滤过治疗中的应用[J]. 交通医学, 2021, 35(4): 380-383. https://doi.org/10.19767/j.cnki.32-1412.2021.04.017
|
[17]
|
Weinberg, J.M., Venkatachalam, M.A., Roeser, N.F., et al. (2000) Mitochondrial Dysfunction during Hypoxia/Reoxy- genation and Its Correction by Anaerobic Metabolism of Citric Acid Cycle Intermediates. Proceedings of the National Academy of Sciences of the United States of America, 97, 2826-2831. https://doi.org/10.1073/pnas.97.6.2826
|
[18]
|
Feldkamp, T., Weinberg, J.M., Horbelt, M., et al. (2009) Evidence for Involvement of Nonesterified Fatty Acid-Induced Protonophoric Uncoupling during Mitochondrial Dys-function Caused by Hypoxia and Reoxygenation. Nephrology Dialysis Transplantation, 24, 43-51. https://doi.org/10.1093/ndt/gfn436
|
[19]
|
金源源, 诸炳骅, 费雪洁, 等. 局部枸橼酸抗凝在肝衰竭患者连续性肾脏替代治疗中的应用[J]. 临床肝胆病杂志, 2021, 37(1): 200-203. https://doi.org/10.3969/j.issn.1001-5256.2021.01.044
|
[20]
|
Bagshaw, S.M., Darmon, M., Ostermann, M., et al. (2017) Current State of the Art for Renal Replacement Therapy in Critically Ill Patients with Acute Kidney Injury. Inten-sive Care Medicine, 43, 841-854.
https://doi.org/10.1007/s00134-017-4762-8
|
[21]
|
Schultheiss, C., Saugel, B., Phillip, V., et al. (2012) Continuous Venovenous Hemodialysis with Regional Citrate Anticoagulation in Patients with Liver Failure: A Prospective Observa-tional Study. Critical Care, 16, R162.
https://doi.org/10.1186/cc11485
|
[22]
|
Zhang, W., Bai, M., Yu, Y., et al. (2019) Safety and Efficacy of Regional Citrate Anticoagulation for Continuous Renal Replacement Therapy in Liver Failure Patients: A Systematic Review and Meta-Analysis. Critical Care, 23, 22.
https://doi.org/10.1186/s13054-019-2317-9
|
[23]
|
Ma, Y., Chen, F., Xu, Y., et al. (2019) Safety and Efficacy of Re-gional Citrate Anticoagulation during Plasma Adsorption plus Plasma Exchange Therapy for Patients with Acute-on-Chronic Liver Failure: A Pilot Study. Blood Purification, 48, 223-232. https://doi.org/10.1159/000500408
|
[24]
|
Rodriguez, K., Srivaths, P.R., Tal, L., et al. (2017) Regional Citrate Anti-coagulation for Continuous Renal Replacement Therapy in Pediatric Patients with Liver Failure. PLoS ONE, 12, e182134.
https://doi.org/10.1371/journal.pone.0182134
|
[25]
|
宁琪琪, 高原, 段美丽, 等. 局部枸橼酸抗凝在接受连续性肾脏替代治疗的肝病合并急性肾损伤中的应用效果观察[J]. 临床肝胆病杂志, 2020, 36(5): 1055-1058. https://doi.org/10.3969/J.ISSN.1001-5256.2020.05.021
|
[26]
|
Klingele, M., Stadler, T., Fliser, D., et al. (2017) Long-Term Continuous Renal Replacement Therapy and Anticoagulation with Citrate in Critically Ill Patients with Severe Liver Dysfunction. Critical Care, 21, 294.
https://doi.org/10.1186/s13054-017-1870-3
|
[27]
|
Balik, M., Zakharchenko, M., Otahal, M., et al. (2012) Quantifi-cation of Systemic Delivery of Substrates for Intermediate Metabolism during Citrate Anticoagulation of Continuous Re-nal Replacement Therapy. Blood Purification, 33, 80-87. https://doi.org/10.1159/000334641
|
[28]
|
樊启晨, 丁峰. 血液净化治疗中局部枸橼酸抗凝时的钙管理[J]. 上海医药, 2018, 39(9): 6-11.
https://doi.org/1006-1533(2018)09-0006-06
|
[29]
|
Zhang, L., Liao, Y., Xiang, J., et al. (2013) Simplified Regional Citrate Anticoagulation Using a Calcium-Containing Replacement Solution for Continuous Venovenous Hemofiltration. Journal of Artificial Organs, 16, 185-192.
https://doi.org/10.1007/s10047-012-0680-2
|
[30]
|
Saner, F.H., Treckmann, J.W., Geis, A., et al. (2012) Efficacy and Safety of Regional Citrate Anticoagulation in Liver Transplant Patients Requiring Post-Operative Renal Replacement Therapy. Nephrology Dialysis Transplantation, 27, 1651-1657. https://doi.org/10.1093/ndt/gfr510
|
[31]
|
Slowinski, T., Morgera, S., Joannidis, M., et al. (2015) Safety and Efficacy of Regional Citrate Anticoagulation in Continuous Venovenous Hemodialysis in the Presence of Liver Failure: The Liver Citrate Anticoagulation Threshold (L-CAT) Ob-servational Study. Critical Care, 19, 349. https://doi.org/10.1186/s13054-015-1066-7
|
[32]
|
Yu, Y., Peng, S., Cen, Z., et al. (2018) Applying Regional Citrate Anticoagulation in Continuous Renal Replacement Therapy for Acute Kidney Injury Patients with Acute Liver Dysfunction: A Retrospective Observational Study. Kidney and Blood Pressure Re-search, 43, 1065-1074. https://doi.org/10.1159/000491057
|
[33]
|
林金锋, 田李均, 王亚东, 等. 肝衰竭患者行局部枸橼酸抗凝连续性肾脏替代治疗时发生枸橼酸蓄积的危险因素分析[J]. 中华危重病急救医学, 2021, 33(2): 211-215. https://doi.org/10.3760/cma.j.cn121430-20201102-00698
|
[34]
|
Ma, Y., Chen, F., Liu, C., et al. (2020) A Novel Predictive Score for Citrate Accumulation among Patients Receiving Artificial Liver Support System Therapy with Regional Citrate Anticoagulation. Scientific Reports, 10, Article No. 12861. https://doi.org/10.1038/s41598-020-69902-2
|
[35]
|
Forsal, I., Nilsson, A., Bodelsson, M., et al. (2021) Mathemati-cal Modelling of Post-Filter Ionized Calcium during Citrate Anticoagulated Continuous Renal Replacement Therapy. PLoS ONE, 16, e247477.
https://doi.org/10.1371/journal.pone.0247477
|